Management's Plans for Continuing Operations (Details Narrative) (USD $)	12 Months Ended
	Dec. 29, 2012	Dec. 31, 2011
Management's Plans for Continuing Operations
Net loss	$ (11,662,426)	$ (7,894,984)
Net operating loss	(11,636,434)	(7,864,239)
Share based compensation Expense	2,703,253
Investor relations expense	987,399	517,891
Severance Payment	671,000
Sales and marketing expenses for BluScience	3,292,207
Sales promotion, sales discounts and returns for BluScience	3,778,341
Warrants outstanding	7,803,564
Exercise price	$ 0.21
Additional proceeds	1,638,748
Total sale transaction estimated value	6,200,000
Non - refundable cash deposit	250,000
Additional cash payment at closing	250,000
Additional cash payment within 60 days	500,000
Senior secured note	2,500,000
Senior secured note convertible into Preferred I Stock	625,000
Quarterly senior note payment	$ 416,667
Preferred shares convertible into Class A Common Shares	669,708
Class A Common Shares	2,678,832
Class A deemed price per share	$ 1